Tamoxifen for DCIS

Kevin Fox, MD
Last Modified: February 3, 2002


Dear OncoLink "Ask The Experts,"

I recently was diagnosed with high nuclear grade, multifocal, comedo-necrosis type DCIS. I underwent a modified radical mastectomy. No invasive cancer was found, & all 13 nodes excised were negative.

Estrogen receptor status was not done as the clinical guidelines in Canada indicate no further treatment is necessary. Is Tamoxifen warranted as further treatment in this type of DCIS, esp. for protection for the other breast? Is it only effective on ER+ receptors?  


Kevin Fox, MD, Assistant Director, Clinical Affairs and Associate Professor of Hematology/Oncology at the Abramson Cancer Center of the University of Pennsylvania responds:

Tamoxifen will benefit you only insofar as it may lower the risk of breast cancer in the opposite breast. Your DCIS has been treated adequately with surgery; tamoxifen will provide no additional treatment benefit in regard to the breast that was removed. Estrogen receptors are not factored into the management of DCIS as opposed to invasive cancer.


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Surgery for Low-Grade DCIS May Not Improve Survival

Jun 4, 2015

No difference found in survival for women with low-grade DCIS who did or did not have surgery

Transdermal 4-Hydroxytamoxifen Gel Beneficial in DCIS

Jul 22, 2014

Decrease in Ki67 similar to that with oral tamoxifen; reduced endocrine, coagulation effects

Most ask and advise patients about smoking, but many go no further

Jun 24, 2010

Most ask and advise patients about smoking, but many go no further